The first time I served as a deal lead was unintentional. I happened upon a team I really liked, going after a market I thought was really attractive, with a solution I thought was really smart. So I started telling other investors about it. Many perked up and took an interest, but nothing was really happening because there was no bandwagon to jump onto.
- Clinical Trial Confirms GammaTile Superior Tumor Control
 - 2025 Brutal Biotech Investment Climate
 - Delta Development Team – Introducing BloodCOMM Premium
 - Special Operations Forces Blood Cooler from Delta Development
 - UACI startup alumni Reglagene making impressive strides in brain cancer treatment
 - Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
 - Calls for More Angel Investing
 - Takes a Licking and Keeps on Ticking
 - Ventura County firefighters make history with in-the-field blood transfusions
 - FireRescue1’s “3 Things We’re Watching at FDIC 2025